(Q31633427)

English

Altered regulation of cell cycle machinery involved in interleukin-1-induced G(1) and G(2) phase growth arrest of A375S2 human melanoma cells

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Altered regulation of cell cycle machinery involved in interleukin-1-induced G(1) and G(2) phase growth arrest of A375S2 human melanoma cells (English)

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

author name string

Murai T

1

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Nakagawa Y

2

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Maeda H

3

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Terada K

4

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

language of work or name

0 references

publication date

29 November 2000

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

number of pages

10

1 reference

based on heuristic

inferred from page(s)

Journal of Biological Chemistry

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

276

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

6797-6806

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Phase I trial of escalating doses of interleukin-1 beta in combination with a fixed dose of interleukin-2.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Phase II trial of interleukin 1 alpha and indomethacin in treatment of metastatic melanoma

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Effects of interleukin-1 alpha on ovarian carcinoma in patients with recurrent disease.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Phase I trial of subcutaneous interleukin-1 alpha in children with malignant solid tumors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Phase 1 Trial of Recombinant Human Interleukin-1β (rhIL-1β), Carboplatin, and Etoposide in Patients with Solid Cancers: Southwest Oncology Group Study 8940

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Antiproliferative effect of interleukin 1 (IL-1) on tumor cells: G0-G1 arrest of a human melanoma cell line by IL-1.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Interleukin-1 induces growth arrest by hypophosphorylation of the retinoblastoma susceptibility gene product RB.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Transfection of human melanoma cells with type I interleukin-1 (IL-1) receptor cDNA rendered them IL-1-responsive and revealed the importance of ODC activity down-regulation in IL-1-induced growth inhibition.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

The zinc finger transcription factor EGR-1 impedes interleukin-1-inducible tumor growth arrest

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Cyclins and cancer. II: Cyclin D and CDK inhibitors come of age

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

G1 phase progression: cycling on cue

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

The retinoblastoma protein and the regulation of cell cycling

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Integration of cell cycle control with transcriptional regulation by the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Joining the complex: cyclin-dependent kinase inhibitory proteins and the cell cycle

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Inhibitors of mammalian G1 cyclin-dependent kinases

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

A simple, sensitive bioassay for the detection of interleukin-1 using human melanoma A375 cell line.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Inhibition of cyclin-dependent kinases by p21

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

p21-containing cyclin kinases exist in both active and inactive states

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Cyclin-dependent kinases are inactivated by a combination of p21 and Thr-14/Tyr-15 phosphorylation after UV-induced DNA damage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

p27, a novel inhibitor of G1 cyclin-Cdk protein kinase activity, is related to p21

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

New functional activities for the p21 family of CDK inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Principles of CDK regulation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Potent prostaglandin A1 analogs that suppress tumor cell growth through induction of p21 and reduction of cyclin E.

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Cyclin D-CDK subunit arrangement is dependent on the availability of competing INK4 and p21 class inhibitors

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

The p21(Cip1) and p27(Kip1) CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Cdc25M2 activation of cyclin-dependent kinases by dephosphorylation of threonine-14 and tyrosine-15

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Human cyclin E, a nuclear protein essential for the G1-to-S phase transition

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Growth suppression by p16ink4 requires functional retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

pRB plays an essential role in cell cycle arrest induced by DNA damage

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Growth inhibition by TGF-beta linked to suppression of retinoblastoma protein phosphorylation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Cardiac fibroblasts arrest at the G1/S restriction point in response to interleukin (IL)-1beta. Evidence for IL-1beta-induced hypophosphorylation of the retinoblastoma protein

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

E2F-5, a new E2F family member that interacts with p130 in vivo

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

E2F-4, a new member of the E2F transcription factor family, interacts with p107

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

A unique role for the Rb protein in controlling E2F accumulation during cell growth and differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Multiple change in E2F function and regulation occur upon muscle differentiation

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Destruction of tumor cells by monokines released from activated human blood monocytes: evidence for parallel and additive effects of IL-1 and TNF

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Mechanism of in vitro antitumor effects of interleukin 1 (IL 1)

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

TGF-beta-induced cell-cycle arrest through the p21(WAF1/CIP1)-G1 cyclin/Cdks-p130 pathway in gastric-carcinoma cells

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

The G1-phase growth-arresting action of interleukin-1 is independent of p53 and p21/WAF1 function

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members

1 reference

https://api.crossref.org/works/10.1074%2FJBC.M009355200

21 January 2018

Identifiers

10.1074/JBC.M009355200

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

3 July 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q31633427&oldid=1950438591"